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Abstract
Background: The FACT-G has gone through many validation studies. However, little research
has been conducted in South American Spanish speaking patients. The present study aimed to
evaluate the FACT-G Spanish Version 4 in Uruguayan cancer patients.
Methods: The data analyzed were collected from 309 patients, with various tumor sites, at
different stages of disease and receiving different treatments.
Results: Reliability was evaluated using Cronbach's coefficient alpha and showed high internal
consistency for each of the subscales and its total scale (range = .78 – .91) of the FACT-G. The
FACT-G total score also showed significant mean differences among known groups (performance
status, in vs. outpatients) when tested by ANOVA and t-test. When the tumor stage (Local and
Regional vs. Metastatic disease) was used as a clinical anchor, the FACT-G total score, the Physical
Well-being (PWB), and Functional Well-being (FWB) subscale scores showed mean differences,
ranging from 5 to 10 points in a scale from 0–108 (effect sizes = 0.30–0.60). Item response theory
(IRT)-based evaluation using mean square fit statistics (.60–1.4) criteria showed that only two items
misfit: "Estoy satisfecho(a) con mi vida sexual" (I am satisfied with my sex life) and "Estoy
satisfecho(a) de cómo estoy enfrentando mi enfermedad" (I am satisfied with how I am coping with
my illness).
Conclusion: The results indicated that, using both traditional and IRT approaches, the Spanish
FACT-G has good reliability and validity to be used as a QOL instrument among Uruguayan cancer
patients.
Background
The Functional Assessment of Cancer Therapy-General
(FACT-G) Questionnaire, designed to measure quality of
life (QOL) in cancer patients [1], has gone through many
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validation studies, both in its English and translated ver-
sions [2–5]. However, little research has been conducted
in South American Spanish speaking patients. A previous
study performed among Uruguayan cancer patients using
FACT-G Spanish Version 2 [6] showed acceptable to good
reliability and validity except for the emotional well-being
subscale. Cella and his colleagues also recognized this
potential problem and subsequently revised the items in
a new Spanish Version 3 and its most recent Spanish Ver-
sion 4[2] in order to improve its reliability. Major changes
include adding one previously available but not scored
item to the scoring algorithm ("I worry my condition will
get worse" – "Me preocupa que mi enfermedad
empeore"), rephrasing some other items to improve read-
ability and removing the 2-item Relationship with Doctor
subscale. These remarks the need for additional validation
studies for the Spanish-speaking cancer patient popula-
tion in South America.
Another reason for further psychometric studies on FACT-
G is that, up to date, its Spanish version has been validated
using classic test theory (CTT) approaches like other QOL
questionnaires. Traditionally, classical psychometric
based procedures have dominated the health status assess-
ment. More recently, item response theory (IRT) measure-
ment models have entered the field and researchers are
increasingly enthusiastic for the prospect of deriving bet-
ter definitions of underlying constructs and the opportu-
nity to turn attention away from static tests and scales to
items and the incremental information they provide [7].
The present study aimed to evaluate the performance of
the FACT-G Spanish Version 4 in Uruguayan cancer
patients using both classic psychometric and item
response theory based approaches.
Methods
Patients
The data were collected from cancer patients, between 18
and 75 years of age, with various tumor sites, at different
stages of disease and under different forms of treatment.
To be eligible patients must have been fluent in Spanish.
Potential participants were identified from the daily
record of office visits, treatment visits and inpatient hospi-
talizations. To ensure sufficient experience with treatment
related side-effects, patients must have completed a mini-
mum of two cycles of chemotherapy and/or 10 radiation
therapy sessions or one month of hormone therapy. There
must have been at least one month since last surgery. To
ensure heterogeneity of the socioeconomic features,
patients from one private (Centro de Asistencia del Sindi-
cato Médico del Uruguay – CASMU) and three public
(Hospital de Clínicas de la Universidad de la República,
Instituto de Oncología del MSP, Servicio de Oncología
Radioterápica del Hospital Pereira Rossell) hospitals of
the city of Montevideo were recruited for the study.
Patients with ostensible cognitive deficits or serious psy-
chiatric dysfunctions were excluded. Ability to give
informed consent was required. Approval from the corre-
sponding ethics committees was obtained.
Measures
Patients were assessed using a battery of instruments. Two
physician rated QOL questionnaires, the ECOG Perform-
ance Status Rating and the Spitzer's Quality of Life-Index
doctor version (QLI-d) were completed either by the treat-
ing physician or oncologist. Patient self-reported ques-
tionnaires included the Functional Assessment of Cancer
Therapy-General (FACT-G) Spanish Version 4, the
Spitzer's Quality of Life-Index patient version (QLI-p), the
Profile of Mood States, Short Form (POMS-SF) and the
Marlowe-Crowne Social Desirability Scale (MCSDS).
ECOG Performance Status Rating (ECOG PSR) is a five-
point scale [8] ranging from 0 (fully ambulatory) to 4 (not
being able to leave bed).
The Quality of Life Index (QL-I) [9] is a five-item question-
naire where each one of them explores a dimension or
domain of quality of life: health, activity, daily living, sup-
port and outlook. Every item has three response categories
indicating different levels of functional impairment.
Although it was originally developed as an observer rated
scale (QLI-d), it can also be used as a patient rated scale
(QLI-p). For the purpose of the study, the QL-I was trans-
lated into Spanish following a forward and backward
translation procedure, carried out by an English native
speaking linguist and a native Spanish-speaking English
translator. The Spanish versions of the two QLI question-
naires are available from the authors upon request.
The Functional Assessment of Cancer Therapy-General Ques-
tionnaire (FACT-G) Spanish Version 4[2] is a widely used
QOL instrument. It comprises 27 questions that assess
four primary dimensions of QOL: physical (PWB; 7
items), social and family (SFWB; 7 items), emotional
(EWB; 6 items), and functional well-being (FWB; 7
items). It uses 5-point Likert-type response categories
ranging from 0 = 'not at all' to 4 = 'very much'. The total
FACT-G score is the summation of the 4 subscale scores
and ranges from 0 to 108. Data from a previous study on
the FACT-G Spanish version 2[6] conducted among Uru-
guayan cancer patients suggested that its reliability was
acceptable to good in all subscales except for the EWB
scale. An important question raised by these results was
whether these subscales showed sufficient internal con-
sistency to justify their use across cultures and whether
there was equivalence of the Spanish EWB to its English
counterpart. Ever since, developers of the FACT-G revised
the questionnaire into its most recent version 4 [2]. Major
changes were the inclusion of an additional item ("I worryHealth and Quality of Life Outcomes 2003, 1 http://www.hqlo.com/content/1/1/32
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my condition will get worse" – "Me preocupa que mi
enfermedad empeore") in the EWB subscale, the removal
of the two-item "Relationship with the Doctor" subscale
and the rewording of 12 Spanish items to improve their
readability.
The Profile of Mood States, Short Form (POMS-SF)[10] is a
widely used scale measuring subjective mood states, such
as anxiety, tension, vigor, depression, fatigue and confu-
sion. The POMS-SF is a valid measure of affective states
and psychological adjustment in cancer patients and is
available in Spanish. A Total Mood Disturbance score
(POMS TMD) may be obtained by summing the five
scores of Tension, Depression, Anxiety, Fatigue and Con-
fusion subscales and substracting Vigor from these scores.
Only patients with a 6th grade or higher level of reading
abilities were included in the analysis, according to the
instrument developers' instructions.
The  Marlowe-Crowne Social Desirability Scale (MCSDS)
[11]. The 10 items short form of the MCSDS provides a
measure of the degree to which participants endorse
socially desirable characteristics. A validated Spanish ver-
sion of the questionnaire [12] was completed by the study
participants.
Demographic, disease and treatment information was col-
lected from patients, the treating physician and verified by
the research assistants with the participants' medical
record.
Statistical analysis
Classical psychometric approach for analysis of the data
consisted of an examination of the reliability and validity
of the FACT-G Version 4. Reliability was examined by
internal consistency (Cronbach's coefficient alpha) for
each subscale and the overall scale. Alpha coefficients of
0.70 or higher were considered acceptable [13]. Construct
validity was assessed by comparing mean differences in
FACT-G total and subscale scores according to known
groups, i.e. patients performance status, in vs. out-patients
and by studying the correlations between the instruments
(convergent and discriminant validity).
Several methods have been described in order to establish
clinical significance of QOL measures [14]. Anchor-based
methods examine the relationship between scores on the
instrument whose interpretation is under question (target
instrument) and some independent measure (an anchor).
This approach requires that 1) the anchor is easily inter-
pretable and 2) there must be appreciable association
between the target and the anchor. Differences in scores in
relation to the clinical anchors can be then used to set the
minimum important difference or clinically meaningful
change [15] in order to evaluate outcomes in clinical tri-
als. Anchor-based clinical significance was studied in
order to determine clinically significant differences in
QOL assessments as measured by FACT-G total and sub-
scale scores, using tumor stage as a definite clinical crite-
rion commonly used in the Oncology field[16].
Differences of 5 to 10 score points in a 100 point scale are
considered relevant in determining the clinical signifi-
cance of QOL measures [17]. To examine the statistical
magnitude of the observed differences, each mean differ-
ence score was standardized by relating this score to its
standard deviation (effect size). An effect size of d = 0.2
was taken to indicate a small difference, d = 0.5 a moder-
ate difference, and d = 0.8, a large one [18].
Rasch analysis
The item response data were analyzed using Andrich's
[19–22] rating scale model (RSM). The RSM is an item
response theory (IRT)-based measurement model and has
been implemented in the WINSTEPS computer program
[23]. The RSM specifies two facets (person latent trait, Bn;
item location, Di), and the step threshold (Fi). The proba-
bility of person n responding in response category j to
item i can then be expressed by the formula:
ln [Pnij / Pni(j-1) ] = Bn - Di - Fj,
in which Pnij is the probability of person n endorsing or
choosing in category j of item i, Pni(j-1) is the probability of
person n endorsing or choosing in category j - 1 of item i,
Bn is the latent trait measure (e.g., fatigue) of person n, and
Di is the location of item i, and Fj is the step threshold
between categories j - 1 and j. In the present study, for
example, F1 is the transition from intensity category 1
("not at all") to category 2 ("a little bit") and F4 is the tran-
sition from category 4 ("quite a bit") to category 5 ("very
much"). That is the point on the latent trait scale (i.e.,
PWB) at which two consecutive category response curves
intersect.
Item fit statistics
In order to examine the fit of each item to measure a uni-
dimensional construct (e.g., PWB), the infit and outfit
mean square (MNSQ) item fit statistics provided in the
WINSTEPS program were evaluated. Fit implies meeting
the measurement requirements of item homogeneity and
unidimensionality. It also indicates the validity of the
item calibrations and person measures. Item misfit indi-
cates that an item is not measuring the same underlying
construct as other items within the same scale.
The infit MNSQ is an information-weighted fit statistic,
which is more sensitive to unexpected behavior affecting
responses to items near the person's trait level. The
weighting reduces the influence of less informative, low
variance, off-target responses. The outfit MNSQ is anHealth and Quality of Life Outcomes 2003, 1 http://www.hqlo.com/content/1/1/32
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outlier-sensitive fit statistic, more sensitive to unexpected
behavior by persons on items far from the person's trait
level. These statistics have an expected value of 1.0, and
range from 0 to infinity. Values substantially below 1 indi-
cate local dependencies in the data; values substantially
above 1 indicate noise. These values are on a ratio scale,
so that 1.2 indicates 20% excess noise. We set .60–1.4 for
infit MNSQ and outfit MNSQ as cut-off criteria for items
with good fit.
Results
A total of 361 patients were approached and asked to par-
ticipate. Among them, 36 patients (10%) either refused to
participate, were too sick to complete the battery of ques-
tionnaires or a family member prevented the patient from
participating. Data collection for 16 other participants
(4%) was not completed due to other reasons. There were
no significant differences between participants and non-
participants with regard to age, gender, institution or
tumor stage, however more non-participants were in-
patients (chi-square = 13.5, p = .001) and rated higher in
the ECOG PSR ratings (chi-square = 7.0, p = .03). The
study analysis was based on the remaining 309 patients.
Detailed demographic and clinical information about
these patients can be found in Table 1. Certain facts to be
highlighted are that this is a sample of severely ill patients
with 78% of them having regional and metastatic dis-
eases; only 13.9% of patients being fully employed, 27%
reached less then the sixth year of formal education and
with a very unequal income distribution. The distribution
of income shows a very wide range in monthly income
with an interquartile range of 192 and 571 dollars/month
that highlights the kind of low income and unequal distri-
bution that prevails in South American countries. As
many as 41.7% of patients in the study sample stated not
to have any religion, a typical characteristic of Uruguayan
culture, quite dissimilar to other South American
countries.
Table 1: Socio-demographic and clinical features of the sample (n 
= 309)
N%
Gender
Male 139 45.0
Female 170 55.0
Age
Mean (SD) 56.7 (12.9)
Marital Status
Married 164 53.1
Unmarried couple 20 6.5
Divorced 27 8.7
Separated 16 5.2
Widow 37 12.0
Single 45 14.6
Family living
Lives alone 36 11.7
Lives with family 259 83.8
Lives with others 11 3.6
Lives in institution 3 1.0
Years of education
Primary School <3 years 36 11.7
Primary School 3 to 5 years 46 14.9
Primary School 6 years 101 32.7
High School 1 to 3 years 51 16.5
High School 4 to 6 years 32 10.4
College/University 40 12.9
Employment
Full-time 43 13.9
Part-time 17 5.5
Retired 107 34.6
Social welfare 3 1.0
Unemployed 64 20.7
Medical leave 22 7.1
Housekeeping 40 12.9
Others 9 2.9
n%
Satisfaction with income
"I can save" 10 3.2
"I get enough, no money problems" 23 7.4
"I get just fair for my needs" 100 32.4
"I don't get enough for my needs" 136 44.0
"I am in need" 38 12.3
Family monthly income in US 
dollars
Means 512
Median 300
Range 0 – 5000
Interquartile range 192 – 571
Religion
No 129 41.7
Yes 180 58.3
Tumor site
Breast 98 31.7
Lung 44 14.2
Colorectal 35 11.3
Head & Neck 24 7.8
Uterus & ervix 20 6.5
Prostate 18 5.8
Testicle 16 5.2
Gastrointestinal 12 3.9
Urothelial 12 3.9
Ovary 8 2.6
Lymphoma 7 2.3
Primitive unknown 7 2.3
Soft tissue 4 1.3
Melanoma 3 1.0
Brain 1 .3
Tumor stage
In situ 2 .6
Local 64 19.9
Regional 132 41.0
Metastatic 118 37.2
Table 1: Socio-demographic and clinical features of the sample (n 
= 309) (Continued)Health and Quality of Life Outcomes 2003, 1 http://www.hqlo.com/content/1/1/32
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Mean time since cancer diagnosis was 29 months (SD =
39.5 months; ranged 2 weeks to 24.5 years). As for treat-
ment characteristics, 172 patients had undergone surgery
(55.7%); 204 received only one treatment modality, 95 of
them were treated with chemotherapy (ChT) (30.7%), 98
with radiotherapy (RT) (31.7%) and 11 with hormone
therapy (HT) (3.6%), while 100 patients received a com-
bination of ChT and RT; 4 (1.3%) were treated with RT
and HT and 1 (0.3%) with ChT and HT. The timing of test-
ing in relation to treatment varied along the sample. In
119 cases (38.5%), patients were interviewed during the
week following their last treatment (ChT cycle or RT ses-
sion); in 64 cases (20.7%) there had been between one
week and one month since the last treatment; in 44 cases
(14.2%) between 3 months and a year and 82 (26.5%)
had been off treatment for more than one year.
The mode of administration of the FACT-G (self-adminis-
tration vs. read in interview) was registered in 303 cases.
Although the FACT-G is designed for self-administration,
most patients in our sample (n = 205, 67.7%) requested
some help from the interviewer to fill out the question-
naire. Figures 1,2,3,4 show differences in sociodemo-
graphic and somatic features of the two groups of patients.
T-test of independent samples showed that those patients
capable of self administration were younger (p < .000)
while chi-square statistics showed that this group of
patients had a higher education level (p < .000) and better
performance status (lower ratings in ECOG scale) (p <
.000). No differences in gender were observed.
Reliability
The reliability of the each of the FACT-G scales was evalu-
ated with Cronbach's coefficient alpha. The alpha coeffi-
cients for the total scale and the four FACT subscales
(PWB, SFWB, EWB, FWB) were quite good (ranged .78 –
.91; See Table 2). Table 2 also shows alpha coefficients of
FACT-G English and Spanish Version 2. No relevant dif-
ferences were found in Cronbach alpha coefficients for
Total FACT-G and its subscales when the group of patients
who filled out the questionnaires by self administration
(Cronbach's alpha = .78 – .91) and by interview (Cron-
bach's alpha = .79 – .89) were studied separately.
Validity
Mean score differences among known groups were tested
by ANOVA or t-test. Scheffé post-hoc comparisons
showed significant differences in FACT-G total and sub-
scale scores according to ECOG PSR (Table 3), indicating
that patients with worse functional status rated lower in
the QOL multidimensional assessment. Due to the small
number, patients rated "3" or "4" on ECOG PSR were
combined with individuals rated "2". Total FACT-G scores
and subscale scores, with the exception of the PWB sub-
scale, also enabled to discriminate among groups accord-
ing to patient location at the moment of filling out the
questionnaire (out-patient vs. in-patient), see Table 3.
As another evidence of validity, tumor stage (Local vs.
Regional vs. Metastatic disease) was examined as a clinical
anchor and differences in mean scores and effect sizes
were calculated (Table 4). Differences of approximately 5
to 10 % points in total FACT-G score (5.6 to 10.5 points
Differences in mode of administration with age Figure 1
Differences in mode of administration with age
Differences in mode of administration with gender Figure 2
Differences in mode of administration with genderHealth and Quality of Life Outcomes 2003, 1 http://www.hqlo.com/content/1/1/32
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in a 108 point scale) were observed between local vs. met-
astatic and regional vs. metastatic diseases. Accordingly
differences of 11 to 18% points in the PWB subscale score
(3 to 5 points in a 28 point subscale) and of 9% in the
FWB subscales (2.6 points in a 28 point subscale) were
observed between the ratings of patients with local and
regional diseases vs. those with spread forms of cancer.
Calculated effect sizes of these differences ranged between
0.30–0.60.
Convergent and discriminant validity was evaluated using
data from the whole set of patients with the exception of
the POMS-SF questionnaire. In this case, only patients
that had completed the sixth grade of primary school and
higher were included according to the POMS manual's
instructions. As expected, Pearson correlation coefficients
were high between the FACT-G total score and its subscale
scores, ranging from r = .53 to r = .80, see Table 5. Simi-
larly, moderate but statistically significant correlations (r
= .30 and higher) were observed between QL-I total score
in both doctor and patient versions as well as between QL-
I items and the corresponding FACT-G subscales (QL-Id
and QL-Ip Activity, Daily Living and Health and FWB; QL-
Id and QL-Ip Support and SFW), (Table 5). Correlation
between the FACT-G and the POMS-SF Total Mood Dis-
turbance Score (POMS TMD) is also relatively high. As
expected, the correlation coefficients between the FACT-G
total and subscale scores and the MCSDS-10 are low.
Differences in mode of administration with education Figure 3
Differences in mode of administration with educationHealth and Quality of Life Outcomes 2003, 1 http://www.hqlo.com/content/1/1/32
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Differences in mode of administration with ECOG-PSR Figure 4
Differences in mode of administration with ECOG-PSR
Table 2: Internal consistency of FACT-G and subscales
English Version 2 [1] Spanish Version 2 [6] Spanish Version 4
Subscale Mean ± SD Alpha coefficients Mean ± SD Alpha coefficients Mean ± SD Alpha coefficients
PWB (7 items) 20.5 ± 5.5 .82 19.0 ± 5.9 .79 15.7 ± 8.9 .91
SFWB (6 items) ----- ---- ----- 16.6 ± 5.1 .82
SFWB (7 items)* 21.9 ± 4.8 .69 18.0 ± 5.7 .65 18.6 ± 5.9 .81
EWB (5 items) 14.8 ± 5.0 .74 14.2 ± 3.7 .60 ----- ----
EWB (6 items) --- ---- ---- 13.5 ± 6.3 .78
FWB (6 items) 18.0 ± 6.1 .80 12.9 ± 5.6 .72 16.0 ± 6.0 .81
Relationship with 
Doctor (2 items)
6.9 ± 1.5 .65 6.8 ± 1.2 .66 ----- ----
Total FACT-G 82.1 ± 15.9 .89 71.9 ± 15.7 .83 61.9 ± 18.4 .89
Total FACT-G (*) 63.7 ± 19.0 .89
PWB = Physical Well-being; FWB = Functional Well-being; SFWB = social and Family Well-being; EWB = Emotional Well-being (*) Includes 
"satisfaction with sexual life".Health and Quality of Life Outcomes 2003, 1 http://www.hqlo.com/content/1/1/32
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Table 3: Differences in FACT-G scores according to criteria groups
Performance Status n FACT Total Physical Functional Social Emotional
Means (SD) Means (SD) Means (SD) Means (SD) Means (SD)
0 133 70.5 (19.7) 17.8 (10.2) 19.7 (5.6) 19.5 (5.7) 14.9 (6.7)
1 94 60.7 (15.8) 14.1 (7.5) 15.0 (4.8) 19.0 (5.4) 12.6 (5.7)
2 – 4 66 57.0 (16.6) 15.3 (8.7) 12.0 (5.5) 17.0 (5.8) 12.7 (6.2)
P <.000 <.00 <.000 <.05 <.00
Subgroup Difference* 0>1,2–4 0>1,2–4 0>1>2–4 0>2–4 0>2–4
Mean score differences by patient location
Patient Location n FACT Total Physical Functional Social Emotional
Means (SD) Means (SD) Means (SD) Means (SD) Means (SD)
Out-patients 223 66.5 (18.5) 16.0 (9.4) 17.2 (5.8) 19.4 (5.3) 13.8 (6.3)
In-patients 86 57.0 (17.0) 14.9 (7.4) 12.8 (5.0) 16.6 (6.4) 12.8 (6.4)
P** <.000 NS <.000 .001 <.000
* Scheffé Comparisons; the symbol > separates groups with scores significantly higher than those with lower scores. ** T test for independent 
samples. Significant p < 0.01
Table 4: Differences in FACT-G and subscale scores with tumor stage and effect size
Tumor stage n FACT – G Total PWB FWB
Means (SD) 95% confidence 
interval
Means (SD) 95% confidence 
interval
Means (SD) 95% confidence 
interval
Local 61 69.8 (20.2) 64.7–75.0 18.3(9.0) 16.0–20.6 17.5(6.4) 15.9–19.2
Regional 129 65.1 (18.9 57.5 – 64.0 16.6(9.3) 15.0–18.2 16.3(5.4) 15.4–17.2
Metastatic 115 59.3 (16.2) 53.0 – 61.1 13.3(7.7) 11.9–14.7 14.9(6.2) 13.8–16.8
Score difference Effect size Score difference Effect size Score difference Effect size
Local – Metastatic 10.5 0.51 5.0 0.55 2.6 0.4
Regional – Metastatic 5.6 0.30 3.3 0.35 --- ---
Table 5: Correlation between FACT-G, QLI doctor and patient version, POMS-SF, MCSDS-10
Subscale/Scale PWB SFWB EWB FWB FACT – G
PWB 1. 0 8 .76** .14* .80**
SFWB 1. 0 7 .48** .53**
EWB 1 .17** .78**
FWB 1 .60**
FACT – G 1
QL-Index doctor version
QLId Activity .20** .18** .19** .45** .35**
QLId Daily Living .11 .13* .08 .36** .23**
QLId Health .11 .12 .14* .37** .25**
QLId Support .02 .30** .02 .20** .17*
QLId Outlook .05 .05 .04 .22** .12
QLId Total .16* .26** .15* .48** .35**
QL-Index patient version
QLIp Activity .07 .22** .10 .51** .30**
QLIp Daily Living .05 .04 .00 .30** .13*
QLIp Health .02 .14* .05 .38** .19**
QLIp Support -.06 .37** -.11 .22** .12*Health and Quality of Life Outcomes 2003, 1 http://www.hqlo.com/content/1/1/32
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QLIp Outlook .03 .11 .13 .28** .19**
QLIp Total .04 .26** .06 .56** .30**
POMS-SF
Tension -15* -.03 -.20** -.32** -.25**
Depression -.10 -.20** -.15* -.50** -.32**
Anxiety -.12 -.19** -.14 -.32** -.27**
Vigor .10 .36** .19** .60** .41**
Fatigue -.10 -.04 -.19** -.33** -.23**
Confusion -.23 -.20** -.27** -.45** -.41**
POMS TMD -.17 -.24** -.25** -.57** -.42**
MCSDS-10
Total MCSDS-10 -.11 .03 -.11 .08 -.06
** Correlation is significant at the 0.01 level. * Correlation is significant at the 0.05 level.
Table 6: IRT based analysis of FACT-G Spanish Version 4.
Physical Well-Being
MEASURE INFIT MNSQ OUTFIT MNSQ ITEM
.07 .84 .79 GP7 I am forced to spend time in bed
.06 .88 1.15 GP1 I have a lack of energy
.04 1.21 1.13 GP3 Because of my physical condition, I have trouble meeting 
the needs of my family
.02 1.05 1.15 GP4 I have pain.
.01 1.23 1.03 GP5 I am bothered by side effects of treatment
-.01 .75 .78 GP6 I feel sick
-.19 1.08 .87 GP2 I have nausea
Social/ Family Well-Being
.80 1.58 1.94 GS7 I am satisfied with my sex life
.23 .89 .88 GS1 I feel close to my friends
.10 1.10 1.08 GS3 I get support from my friends
-.05 .85 1.00 GS4 My family has accepted my illness
-.28 .78 .82 GS5 I am satisfied with family communication about my illness
-.37 1.28 1.24 GS6 I feel close to my partner (or the person who is my main 
support)
-.42 .89 .86 GS2 I get emotional support from my family
Emotional Well-Being
.36 1.22 1.17 GE6 I worry that my condition will get worse
.08 .64 .61 GE1 I feel sad
.08 .95 .82 GE5 I worry about dying
.06 .67 .68 GE4 I feel nervous
-.14 1.01 .86 GE3 I am losing hope in the fight against my illness
-.43 1.57 1.93 GE2 I am satisfied with how I'm coping with my illness
Functional Well-Being
.67 1.11 1.24 GF1 I am able to work (include work at home)
.21 1.03 1.04 GF7 I am content with the quality of my life right now
-.04 1.16 1.21 GF5 I am sleeping well
-.10 1.04 .93 GF2 My work (include work in home) is fulfilling
-.11 .84 .84 GF6 I am enjoying the things I usually do for fun
-.14 .77 .74 GF3 I am able to enjoy life
-.49 1.07 1.08 GF4 I have accepted my illness
Table 5: Correlation between FACT-G, QLI doctor and patient version, POMS-SF, MCSDS-10 (Continued)Health and Quality of Life Outcomes 2003, 1 http://www.hqlo.com/content/1/1/32
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The results of Rasch analyses confirmed the unidimen-
sionality of each subscale of the FACT-G with two
exceptions (see Table 6). Items in each table were listed in
the order of item difficulty. GS7 (I am satisfied with my
sex life) of the SFWB subscale had both MNSQ fit statistics
greater 1.40, indicating it did not perform well with the
other items in the same scale. GE2 (I am satisfied with
how I'm coping with my illness) of the EWB also had large
MNSQ fit statistics, indicating its poor fit to the unidimen-
sionality model with the other items on the same scale.
Discussion
Since most instruments designed to evaluate quality of life
have been developed in the United States or in Western
Europe, it is necessary to adapt them to be used in other
cultural settings. Thus, it is important to produce a cultur-
ally equivalent measure that can be used to accurately
evaluate different groups of people. The final step in the
complex process of cross-cultural adaptation is to validate
the instrument through the study of the psychometric
properties of the measure.
A validation study of the FACT-G Spanish Version 4 was
conducted in a sample of Uruguayan cancer patients. A
large variability in the biological and sociodemographic
features of the sample was ensured to study the general
performance of the questionnaire. The frequency of
tumor sites represents very closely the incidence of solid
tumors in the Uruguayan general population [24].
Reliability analysis showed high internal consistency as
indicated by Cronbach alpha coefficients ranging from
(.78 – .91). The comparison of these data with the results
obtained from the FACT-G English and Spanish Version 2
(Table 2) points out a remarkable improvement in FACT-
G Spanish Version 4 total scale as well as subscale
reliability coefficients. Based on these results it is safe to
conclude that the FACT-G Spanish Version 4 shows suffi-
cient internal consistency to justify its use across cultures.
As an evidence of construct validity, the FACT-G question-
naire appeared to be capable of discriminating among
groups of patients according to their level of performance
status, showing differences in the total scale and subscale
scores with the criterion groups. The FACT-G total and the
Functional Well-being subscale showed the best discrimi-
native ability. Differences among known groups were also
observed in the FACT-G total and subscale scores in rela-
tion to in-patients vs. out-patients. As expected, the FACT-
G scores are higher (better QOL) among outpatients and
differences were statistically significant on the Functional,
Social and Emotional Well-being subscales.
Quality of life researchers have been concerned about the
clinical significance of measures and have pursued the
objective to find practical and comprehensive criteria that
could be interpretable by clinicians when conveying
research results. Clinical status and disease characteristics
were considered as clinical anchors. In our study, differ-
ences ranging from 5 to10 points in the overall scale and
of approximately 3 points in the physical and functional
subscales can be considered clinically relevant since they
can discriminate between patients with loco regional and
metastatic diseases, a clear-cut criterion commonly used
by oncologists. Accordingly, effect size calculations
showed moderate values ranging from 0.30 to 0.60. These
findings are consistent with those found in a longitudinal
study using the FACT-G to assess treatment outcomes in a
sample of advanced lung cancer patients [15].
In CTT, the most common form of construct validation of
HRQL measures has been the study of convergent and dis-
criminant validity [25]. We included it in our study, along
with the more recent IRT approach, because it provides
relevant information on the relationship of the question-
naire with other measures of QOL and related constructs,
i.e., performance status or psychological distress after a
priori hypothesis were made about the magnitude and
direction of the correlations. As an evidence of convergent
validity, moderate but significant, correlations were found
between the FACT-G and a set of instruments (ECOG PSR,
QL-I and POMS-SF) that are expected a priori to be related
to QOL assessments while no correlation was found
between the FACT-G and the MCSDS-10, supporting
divergent validity.
An important issue to be considered is the technical equiv-
alence of the FACT-G when used in a sample of cancer
patients of a South American country [26]. As mentioned
earlier, most patients in the Uruguayan sample preferred
the questionnaire to be read out loud by an interviewer
instead of filling it out by themselves. This is not a com-
mon finding in studies with patients from the United
States. These may raise the issue as to whether this differ-
ence in the method of assessment is comparable in each
culture with respect to the data that it yields. In our study,
the internal consistency of the FACT-G did not vary when
studied separately, by means of the Cronbach alpha coef-
ficients for the FACT-G total and subscale scores for two
groups of patients. In a study of the impact of socio-cul-
tural and clinical factors on Hispanic and African Ameri-
can cancer patients' quality of life, Wan et al [27] also
found no significant effect of the mode of administration
of the FACT-G on the reporting of overall QOL. Recently,
audio-visual computerized based assessments of QOL
provide an innovative way for gathering and using self-
report data and may be feasible for individuals with lim-
ited literacy skills (Hahn et al. unpublished data).Health and Quality of Life Outcomes 2003, 1 http://www.hqlo.com/content/1/1/32
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Based on the CTT approach, we may conclude that Span-
ish FACT-G Version 4 is a psychometrically sound instru-
ment to assess QOL in the population being studied.
However, in the present study, we moved on to introduce
IRT based analyses of the data considering the significant
advantages shown by this method when used to evaluate
health outcomes measures. Despite the long history of
CTT, there remain major limitations in some areas that
have been summarized by Hambleton [28]. First of all,
the CTT-based statistics that describe test performance are
sample dependent. IRT is more useful since it provides
more robust item statistics that are independent and
invariant over sample populations that vary in the trait
measured by the test. Another limitation of CTT is that the
scores that are commonly used as a measure of the exam-
inees' ability are test dependent. Potential advantages of
using IRT in health outcome assessments are: more com-
prehensive and accurate evaluation of item characteristics,
assessment of group differences in item and scale
functioning, evaluation of scales containing items with
different response formats, improvement of existing
measures, computer adaptive testing (CAT) applications,
and evaluation of person fit [29]. Thus, IRT can facilitate
the development of new items and scales to improve exit-
ing measures. It may raise attention on redundant items
or the location along the trait continuum (in our case,
quality of life) where the scale provides little information
and needs to be improved.
An IRT analysis was included in the evaluation of FACT-G
Spanish Version 4 because it provides additional informa-
tion on the reliability of the scale than that provided by
the CTT approach. A rating scale model (RSM) [20] was
used which assumes that the logit-transformed measures
of the item scores within each subscale vary along the
latent trait level (quality of life) and are aligned according
to the difficulty (or location) the patients had to endorse
each item, with negative values representing those items
that are easier to endorse and positive values those that are
more difficult. In the present study, item fit statistics con-
firmed the unidimensionality of each subscale with two
exceptions. In the case of GS7 (I am satisfied with my sex
life), many patients were reluctant to give information
about their sexual life and this may be a cause of inconsist-
ency in their responses. Another reason for discrepancy
may be related to some problem in translation or compre-
hension. In both items (GS7 and GE2) the word "satisfac-
tion" was translated into Spanish as "satisfacción" which
implies in Spanish a degree of fulfillment that patients
may be not prone to express when answering such ques-
tion. Another possible explanation is that these items are
the only ones phrased positively in their respective sub-
scales while the rest of the items refer to negative condi-
tions for quality of life.
Other IRT models could have been used for the analysis of
the data. For instance, the graded response model (GRM),
an extension of the two parameter logistic model [30] is
also appropriate to use when item responses can be char-
acterized as ordered categorical responses. However,
scores obtained using several models were highly corre-
lated showing that these approaches yield comparable
results [31].
IRT analyses demands large sample sizes in order to
obtain stable and invariant item and latent trait estimates.
However, several studies using this procedure to assess the
psychometric properties of QOL measures addressed
rather small sample of patients (range: 100 to 400
patients) [32–37].
Cella and Chang [7] warned of the possible limitations of
using IRT methods in the evaluation of health measures
since they were originally developed for and used with a
fairly homogeneous educational assessment population.
When we apply these methods to more heterogeneous
clinical populations there may be limitations to obtain
item-free estimates of sample latent traits. They remark
that the context, selection and sequence of questions, con-
sidering both item diversity and clinical diversity, may
produce sample-dependent item difficulty estimates and
therefore unreliable item-dependant estimates of patient
ability. The continuous monitoring of item calibrations
involved in the process of item banking will help to solve
these uncertainties.
The present study is the first one in South America report-
ing results on item functioning on a health related quality
of life measure. Future studies with larger sample of
patients could lead to a better understanding of differ-
ences in item functioning across different South American
countries and cultures and move forward to item banking
and CAT technology suitable for developing countries.
Conclusions
We conclude that the FACT-G Spanish Version 4 showed,
using classic psychometric and IRT approaches, good reli-
ability and validity and is a valid instrument to set clinical
significant differences in longitudinal studies of cancer
treatment. Thus, the FACT – G Spanish language version,
as reported here, provides sufficient assurance of equiva-
lence to its original English version to be used in future
research on quality of life among South American Spanish
speaking patients.
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